We are live on ! Find out more
KA

Kozak & Associates Portfolio holdings

AUM $576M
1-Year Est. Return 23.37%
This Fund
S&P 500
This Quarter Est. Return
-5.73%
1 Year Est. Return
+23.37%
3 Year Est. Return
+97.43%
5 Year Est. Return
+117.62%
10 Year Est. Return
–
AUM
$401M
AUM Growth
-$36.6M
Cap. Flow
+$8.16M
Cap. Flow %
2.03%
Top 10 Hldgs %
74.52%
Holding
473
New
34
Increased
162
Reduced
52
Closed
17

Top Buys

Rank Stock Value
1
RWL icon
Invesco S&P 500 Revenue ETF
RWL
+$2M
2
IETC icon
iShares US Tech Independence Focused ETF
IETC
+$1.37M
3
SMH icon
VanEck Semiconductor ETF
SMH
+$950K
4
IYJ icon
iShares US Industrials ETF
IYJ
+$925K
5
IYG icon
iShares US Financial Services ETF
IYG
+$639K

Top Sells

Rank Stock Value
1
XYZ
Block Inc
XYZ
+$168K
2
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$122K
3
XSMO icon
Invesco S&P SmallCap Momentum ETF
XSMO
+$103K
4
SCHW
Charles Schwab
SCHW
+$99.3K
5
JNJ icon
Johnson & Johnson
JNJ
+$97.6K

Sector Composition

Rank Sector Weight
1 Technology 15.57%
2 Consumer Staples 5.36%
3 Consumer Discretionary 4.81%
4 Financials 2.43%
5 Communication Services 1.22%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MRK icon
76
Merck
MRK
$318B
$184K 0.05%
2,318
-574
-20% -$53.6K
SCHA icon
77
Schwab U.S Small- Cap ETF
SCHA
$23B
$183K 0.05%
8,350
– –
VLO icon
78
Valero Energy
VLO
$86.7B
$180K 0.04%
1,632
+14
+0.9% +$1.86K
ZTS icon
79
Zoetis
ZTS
$32.5B
$180K 0.04%
1,193
+36
+3% +$5.99K
PEY icon
80
Invesco High Yield Equity Dividend Achievers ETF
PEY
$1.16B
$176K 0.04%
8,975
+92
+1% +$1.99K
EFA icon
81
iShares MSCI EAFE ETF
EFA
$79.6B
$158K 0.04%
1,985
– –
ELV icon
82
Elevance Health
ELV
$84.3B
$158K 0.04%
358
+2
+0.6% +$803
ADSK icon
83
Autodesk
ADSK
$50.4B
$150K 0.04%
575
– –
CLX icon
84
Clorox
CLX
$12.9B
$145K 0.04%
1,032
+8
+0.8% +$1.22K
ARW icon
85
Arrow Electronics
ARW
$11.5B
$144K 0.04%
1,441
– –
ONT
86
Onterris Inc
ONT
$511M
$142K 0.04%
10,000
– –
CMCSA icon
87
Comcast
CMCSA
$88.9B
$138K 0.03%
4,030
+30
+0.8% +$1.08K
NOC icon
88
Northrop Grumman
NOC
$80B
$128K 0.03%
240
+1
+0.4% +$477
ABT icon
89
Abbott
ABT
$185B
$128K 0.03%
1,002
-144
-13% -$18.3K
T icon
90
AT&T
T
$161B
$126K 0.03%
4,617
+398
+9% +$10K
DIS icon
91
Walt Disney
DIS
$180B
$125K 0.03%
1,474
-123
-8% -$13.2K
AMP icon
92
Ameriprise Financial
AMP
$49.2B
$125K 0.03%
263
+1
+0.4% +$524
IVV icon
93
iShares Core S&P 500 ETF
IVV
$898B
$120K 0.03%
222
-128
-37% -$75.6K
DUK icon
94
Duke Energy
DUK
$96.3B
$118K 0.03%
981
+9
+0.9% +$1.03K
AMGN icon
95
Amgen
AMGN
$218B
$116K 0.03%
396
+24
+6% +$7.09K
LHX icon
96
L3Harris
LHX
$53.9B
$112K 0.03%
504
– –
AFL icon
97
Aflac
AFL
$64.2B
$110K 0.03%
1,016
+5
+0.5% +$530
AZN icon
98
AstraZeneca
AZN
$248B
$109K 0.03%
801
– –
MRSH
99
Marsh
MRSH
$91.4B
$107K 0.03%
449
+29
+7% +$6.58K
DAL icon
100
Delta Air Lines
DAL
$61B
$105K 0.03%
2,596
+29
+1% +$1.72K
2 3
4
5 6

Similar funds

SCM
Simcoe Capital Management New York $576M AUM 36.22% 1-Year Est. Return
GAM
Gould Asset Management Claremont, California $576M AUM 12.34% 1-Year Est. Return
MIOT
Massachusetts Institute of Technology Cambridge, Massachusetts $577M AUM 8.5% 1-Year Est. Return
PG
Patten Group Chattanooga, Tennessee $575M AUM 21.99% 1-Year Est. Return
WCCM
Webs Creek Capital Management Dallas, Texas $578M AUM 79.84% 1-Year Est. Return
BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
IDA
Intelligence Driven Advisers Carlsbad, California $574M AUM 16.47% 1-Year Est. Return
AF
Aegis Financial Mc Lean, Virginia $580M AUM 105.74% 1-Year Est. Return

Kozak & Associates's Q1 2025 Portfolio in Review

As of Q1 2025, Kozak & Associates held 473 positions worth $401M, down 8.4% from $437M the previous quarter. Its ten largest holdings account for 75% of the portfolio.

Kozak & Associates's Q1 2025 filing shows 34 new, 162 increased, 52 reduced and 17 closed positions. Its largest new stake was Madrigal Pharmaceuticals: 324 shares worth $104K. The largest sale was Block Inc, an estimated $168K.

By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 17% a quarter earlier, followed by Consumer Staples and Consumer Discretionary.

  • Kozak & Associates's largest Q1 2025 buy was Madrigal Pharmaceuticals: 324 shares worth $104K.
  • Kozak & Associates added most to Invesco S&P 500 Revenue ETF in Q1 2025, an estimated $2M increase.
  • Kozak & Associates's biggest Q1 2025 reduction was Block Inc, cutting an estimated $168K.
  • Kozak & Associates fully exited State Street SPDR Bloomberg 1-3 Month T-Bill ETF in Q1 2025, selling an estimated $44.8K.
  • Kozak & Associates's ten largest holdings make up 75% of its $401M portfolio in Q1 2025.
  • Kozak & Associates opened 34 new positions and closed 17 in Q1 2025.
  • Kozak & Associates's portfolio value fell 8.4% quarter-over-quarter to $401M.

Based on Kozak & Associates's 13F filing for Q1 2025, filed 15 Apr 2025.